Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Evangelia Vlachodimitropoulou Koumoutsea"'
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2016 (2016)
Ovarian torsion in the third trimester of pregnancy leading to a midline laparotomy and caesarean section for the delivery of a preterm baby is an uncommon event. As the woman is likely to present with nonspecific symptoms of lower abdominal pain, na
Externí odkaz:
https://doaj.org/article/02d2ad822e7740c69e8ea674b451128d
Publikováno v:
Sex and Pregnancy ISBN: 9781009025034
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc3aa880537e2de38f5eeef8603b3a5f
https://doi.org/10.1017/9781009025034.019
https://doi.org/10.1017/9781009025034.019
Autor:
John B. Porter, Somdet Srichairatanakool, Evangelia Vlachodimitropoulou Koumoutsea, Suthat Fucharoen, Chairat Uthaipibull, Pimpisid Koonyosying
Publikováno v:
Pancreas
Supplemental digital content is available in the text.
Objectives We have investigated the efficacy of mono- and combined therapy with green tea extract (GTE) in mobilizing redox iron, scavenging reactive oxygen species (ROS), and improving insu
Objectives We have investigated the efficacy of mono- and combined therapy with green tea extract (GTE) in mobilizing redox iron, scavenging reactive oxygen species (ROS), and improving insu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91f9f56ca609d9dfab6bfcc3310d084
https://doi.org/10.1097/mpa.0000000000001320
https://doi.org/10.1097/mpa.0000000000001320
Autor:
Wendy Whittle, John Snelgrove, Ann Kinga Malinowski, Nadine Shehata, Celine Desconclois, Alexandre J. Vivanti, Agnès Le Gouez, Alexandra Benachi, Evangelia Vlachodimitropoulou Koumoutsea
Publikováno v:
Journal of Thrombosis and Haemostasis
We present a putative link between maternal COVID-19 infection in the peripartum period and rapid maternal deterioration with early organ dysfunction and coagulopathy. The current pandemic with SARS-CoV-2 has already resulted in high numbers of criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b7e57d9a8aee8f7fbbd3375f829e91
Publikováno v:
British journal of haematology. 170(6)
© 2015 John Wiley & Sons Ltd. Iron chelators are increasingly combined clinically but the optimal conditions for cellular iron mobilization and mechanisms of interaction are unclear. Speciation plots for iron(III) binding of paired combinations of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8978e0a0f2138d1f1caa08ced63799
https://pubmed.ncbi.nlm.nih.gov/33469911
https://pubmed.ncbi.nlm.nih.gov/33469911
Autor:
Pimpisid Koonyosying, Bethan Psaila, John B. Porter, Evangelia Vlachodimitropoulou Koumoutsea, Nichola Cooper, Martha Sola-Visner
Publikováno v:
Blood. 128:1278-1278
Introduction: Eltrombopag (ELT) is an orally active, nonpeptide, small-molecule thrombopoietin receptor agonist (TPO-R), used to treat chronic immune thrombocytopenic purpura (ITP). We have recently reported its ability to mobilise cellular iron, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8236c024958c25ecbd280e54cc2765b
https://doi.org/10.1182/blood.v128.22.1278.1278
https://doi.org/10.1182/blood.v128.22.1278.1278
Autor:
Martha Sola-Visner, Bethan Psaila, John B. Porter, Nichola Cooper, Evangelia Vlachodimitropoulou Koumoutsea
Publikováno v:
Blood. 126:3357-3357
INTRODUCTION Eltrombopag (ELT) is an orally available, non-peptide, small-molecule thrombopoietin receptor (TPO-R) agonist approved for the treatment of chronic immune thrombocytopenic purpura (ITP). Additionally ELT appears to bind intracellular iro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f6ce06a2c03074e2a51d454e11e091d
https://doi.org/10.1182/blood.v126.23.3357.3357
https://doi.org/10.1182/blood.v126.23.3357.3357
Autor:
John B. Porter, Bethan Psaila, Evangelia Vlachodimitropoulou Koumoutsea, Nichola Cooper, Martha Sola-Visner
Publikováno v:
Blood. 124:1353-1353
INTRODUCTION Eltrombopag (EP) is an orally bioavailable thrombopoietin receptor agonist developed to increase platelet production in a range of conditions associated with thrombocytopaenia. The finding that EP, in addition to increasing platelet coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a8d6c58872870e8aac06d1b402a6743
https://doi.org/10.1182/blood.v124.21.1353.1353
https://doi.org/10.1182/blood.v124.21.1353.1353